Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Eddy

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Gynecologic Oncology|November 1, 1994
Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two casesG L Eddy, G W Spiegel, W T Creasman
Investigational New Drugs|April 1, 1992
Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG)H B Muss, J A Blessing, G L Eddy, et al.
Gynecologic Oncology|July 1, 1995
Secretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer: a report of a caseJ J Folk, M T Mazur, G L Eddy, et al.
Obstetrics and Gynecology|December 16, 1997
Papanicolaou smears by the Bethesda system in endometrial malignancy: utility and prognostic importanceG L Eddy, M A Wojtowycz, P S Piraino, et al.
American Journal of Obstetrics and Gynecology|August 11, 1991
Primary invasive vaginal carcinomaG L Eddy, R D Marks, M C Miller, et al.
American Journal of Clinical Oncology|February 1, 1993
A phase II trial of vincristine in advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group StudyG O Broun, J A Blessing, G L Eddy, et al.
Gynecologic Oncology|June 1, 1995
Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot studyG L Eddy, A Manetta, R D Alvarez, et al.
American Journal of Obstetrics and Gynecology|December 16, 1997
Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda systemG L Eddy, K B Strumpf, M A Wojtowycz, et al.
Obstetrics and Gynecology|December 1, 1983
Postmolar trophoblastic disease in women using hormonal contraception with and without estrogenG L Eddy, J B Schlaerth, R H Nalick, et al.
Gynecologic Oncology|November 5, 1997
Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda SystemG L Eddy, S H Ural, K B Strumpf, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Gynecologic Oncology|November 1, 1994
Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two casesG L Eddy, G W Spiegel, W T Creasman
Investigational New Drugs|April 1, 1992
Echinomycin (NSC 526417) in recurrent and metastatic squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group (GOG)H B Muss, J A Blessing, G L Eddy, et al.
Gynecologic Oncology|July 1, 1995
Secretory endometrial adenocarcinoma in a patient on tamoxifen for breast cancer: a report of a caseJ J Folk, M T Mazur, G L Eddy, et al.
Obstetrics and Gynecology|December 16, 1997
Papanicolaou smears by the Bethesda system in endometrial malignancy: utility and prognostic importanceG L Eddy, M A Wojtowycz, P S Piraino, et al.
American Journal of Obstetrics and Gynecology|August 11, 1991
Primary invasive vaginal carcinomaG L Eddy, R D Marks, M C Miller, et al.
American Journal of Clinical Oncology|February 1, 1993
A phase II trial of vincristine in advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group StudyG O Broun, J A Blessing, G L Eddy, et al.
Gynecologic Oncology|June 1, 1995
Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot studyG L Eddy, A Manetta, R D Alvarez, et al.
American Journal of Obstetrics and Gynecology|December 16, 1997
Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda systemG L Eddy, K B Strumpf, M A Wojtowycz, et al.
Obstetrics and Gynecology|December 1, 1983
Postmolar trophoblastic disease in women using hormonal contraception with and without estrogenG L Eddy, J B Schlaerth, R H Nalick, et al.
Gynecologic Oncology|November 5, 1997
Incidence of atypical glandular cells of uncertain significance in cervical cytology following introduction of the Bethesda SystemG L Eddy, S H Ural, K B Strumpf, et al.
Pageof 3